Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Former surgeon general says cardiologists need to address hypertension, COVID | Etripamil nasal spray terminates PSVT
Thursday, November 17, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Etripamil nasal spray meets primary endpoint of terminating paroxysmal supraventricular tachycardia 

The drug allows patients to take control over their condition with self administration and the therapy and may help lower healthcare costs and resource utilization by keeping these patients out of emergency rooms. 

READ MORE >
New data from the Phase 3 RAPID clinical trial of etripamil, an investigational calcium channel blocker nasal spray, showed positive results in converting paroxysmal supraventricular tachycardia (PSVT) to normal sinus rhythm in the at-home setting. The presentation was featured during a late-breaking clinical trials session at the American Heart Association (AHA) 2022 Scientific Sessions. #AHA22
Share on Twitter Share on Facebook Share on Linkedin

Etripamil nasal spray meets primary endpoint of terminating paroxysmal supraventricular tachycardia 

Share on Twitter Share on Facebook Share on Linkedin
New data from the Phase 3 RAPID clinical trial of etripamil, an investigational calcium channel blocker nasal spray, showed positive results in converting paroxysmal supraventricular tachycardia (PSVT) to normal sinus rhythm in the at-home setting. The presentation was featured during a late-breaking clinical trials session at the American Heart Association (AHA) 2022 Scientific Sessions. #AHA22
The drug allows patients to take control over their condition with self administration and the therapy and may help lower healthcare costs and resource utilization by keeping these patients out of emergency rooms. 
READ MORE >

Former surgeon general says cardiologists need to address hypertension and remaining COVID cases

Former U.S. Surgeon General Jerome Adams spoke at the AHA 2022 Scientific Sessions and asked cardiologists to help end the COVID pandemic and tackle the even bigger epidemic of hypertension.

READ MORE >
Former U.S. Surgeon General Jerome Adams (2017-2021) spoke at the opening session of the American Heart Association (AHA) 2022 Scientific Sessions last week and said cardiologists need to help end the COVID pandemic and tackle the even bigger epidemic of hypertension. He highlighted hypertension and called it a clear public health emergency, causing more than 670,000 U.S. deaths per year. #AHA22 #hypertension
Share on Twitter Share on Facebook Share on Linkedin

Former surgeon general says cardiologists need to address hypertension and remaining COVID cases

Share on Twitter Share on Facebook Share on Linkedin
Former U.S. Surgeon General Jerome Adams (2017-2021) spoke at the opening session of the American Heart Association (AHA) 2022 Scientific Sessions last week and said cardiologists need to help end the COVID pandemic and tackle the even bigger epidemic of hypertension. He highlighted hypertension and called it a clear public health emergency, causing more than 670,000 U.S. deaths per year. #AHA22 #hypertension
Former U.S. Surgeon General Jerome Adams spoke at the AHA 2022 Scientific Sessions and asked cardiologists to help end the COVID pandemic and tackle the even bigger epidemic of hypertension.
READ MORE >

In Case You Missed It

VIDEO: Key takeaways from AHA 2022

Manesh R. Patel, MD, chair of AHA Scientific Sessions program, explains what he saw as the top takeaways from AHA 2022.

READ MORE >
Late-breaking cardiovascular study presentation at AHA 2022. #AHA22
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: Key takeaways from AHA 2022

Share on Twitter Share on Facebook Share on Linkedin
Late-breaking cardiovascular study presentation at AHA 2022. #AHA22
Manesh R. Patel, MD, chair of AHA Scientific Sessions program, explains what he saw as the top takeaways from AHA 2022.
READ MORE >

VIDEO: Cryoablation can be used as frontline therapy before drugs: PROGRESSIVE AF trial

Jason Andrade, MD, director of electrophysiology, Vancouver General Hospital, and principal investigator of the PROGRESSIVE AF trial, explains how cryoablation can be used as a frontline treatment for atrial fibrillation (AFib) before drugs in this AHA late-breaker. 

READ MORE >
Jason Andrade, MD, FRCPC, FHRS, director of electrophysiology, Vancouver General Hospital, clinical associate professor, University of British Columbia, and principal investigator for the PROGRESSIVE AF trial, explains how cryoablation can be used as a front-line treatment for atrial fibrillation (AFib). He presented this late-breaking trial at the American Heart Association (AHA) 2022 meeting, which showed the therapy can be used instead of trying drug therapy first. #AHA22 #EPeeps
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: Cryoablation can be used as frontline therapy before drugs: PROGRESSIVE AF trial

Share on Twitter Share on Facebook Share on Linkedin
Jason Andrade, MD, FRCPC, FHRS, director of electrophysiology, Vancouver General Hospital, clinical associate professor, University of British Columbia, and principal investigator for the PROGRESSIVE AF trial, explains how cryoablation can be used as a front-line treatment for atrial fibrillation (AFib). He presented this late-breaking trial at the American Heart Association (AHA) 2022 meeting, which showed the therapy can be used instead of trying drug therapy first. #AHA22 #EPeeps
Jason Andrade, MD, director of electrophysiology, Vancouver General Hospital, and principal investigator of the PROGRESSIVE AF trial, explains how cryoablation can be used as a frontline treatment for atrial fibrillation (AFib) before drugs in this AHA late-breaker. 
READ MORE >

VIDEO: The many benefits of spectral CT for cardiovascular imaging

Suhny Abbara, MD, editor of Radiology: Cardiothoracic Imaging and chief of cardiothoracic imaging for University of Texas Southwestern Medical Center, discusses how spectral computed tomography (CT) can help both cardiac and general CT imaging.

READ MORE >
A spectral CT image of the heart showing ischemia in the myocardium by mapping the iodine density in the tissues as a surrogate for bloodflow. Example is from Philips Healthcare, displayed at the 2022 ACC meeting. Example of cardiac perfusion imaging. #SCCT
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: The many benefits of spectral CT for cardiovascular imaging

Share on Twitter Share on Facebook Share on Linkedin
A spectral CT image of the heart showing ischemia in the myocardium by mapping the iodine density in the tissues as a surrogate for bloodflow. Example is from Philips Healthcare, displayed at the 2022 ACC meeting. Example of cardiac perfusion imaging. #SCCT
Suhny Abbara, MD, editor of Radiology: Cardiothoracic Imaging and chief of cardiothoracic imaging for University of Texas Southwestern Medical Center, discusses how spectral computed tomography (CT) can help both cardiac and general CT imaging.
READ MORE >

Around the Web

Amazon marshals partners, providers behind major move into medical imaging

Cloud giant Amazon Web Services is expanding its 1½ -year-old HealthLake data-management service in two imaging-specific directions. In the process it’s drawing vocal buy-in from healthcare providers as well as imaging vendors.

READ MORE >
Amazon is acquiring One Medical in a $3.9 billion deal
Share on Twitter Share on Facebook Share on Linkedin

Amazon marshals partners, providers behind major move into medical imaging

Share on Twitter Share on Facebook Share on Linkedin
Amazon is acquiring One Medical in a $3.9 billion deal
Cloud giant Amazon Web Services is expanding its 1½ -year-old HealthLake data-management service in two imaging-specific directions. In the process it’s drawing vocal buy-in from healthcare providers as well as imaging vendors.
READ MORE >

NorthStar breaks ground on new facility, will offer radiopharmaceutical development services to other companies

The 36,000 square foot unit will be located in Beloit, Wis., alongside NorthStar’s production facilities. It is expected to be open for business starting in 2024.

READ MORE >
NorthStar radiopharmaceutical development facility.
Share on Twitter Share on Facebook Share on Linkedin

NorthStar breaks ground on new facility, will offer radiopharmaceutical development services to other companies

Share on Twitter Share on Facebook Share on Linkedin
NorthStar radiopharmaceutical development facility.
The 36,000 square foot unit will be located in Beloit, Wis., alongside NorthStar’s production facilities. It is expected to be open for business starting in 2024.
READ MORE >

How safe is 7T MRI for patients with neurosurgical implants?

These devices have been tested with lower MRI fields, like 1.5T and 3T, but less is known about their compatibility with more powerful 7T equipment. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

How safe is 7T MRI for patients with neurosurgical implants?

Share on Twitter Share on Facebook Share on Linkedin
These devices have been tested with lower MRI fields, like 1.5T and 3T, but less is known about their compatibility with more powerful 7T equipment. 
READ MORE >

Emergency hospital transfer of STEMI patients might be expedited with a hospital-level 'Call 911 protocol'

The AHA Mission: Lifeline Program was designed to reduce STEMI patient transfer times, but response times still often lag, and new protocols may be needed to expedite STAT transfers.

READ MORE >
The AHA Mission: Lifeline Program was designed to reduce STEMI patient transfer times, but response times still often lag, and new protocols may be needed to expedite STAT transfers.
Share on Twitter Share on Facebook Share on Linkedin

Emergency hospital transfer of STEMI patients might be expedited with a hospital-level 'Call 911 protocol'

Share on Twitter Share on Facebook Share on Linkedin
The AHA Mission: Lifeline Program was designed to reduce STEMI patient transfer times, but response times still often lag, and new protocols may be needed to expedite STAT transfers.
The AHA Mission: Lifeline Program was designed to reduce STEMI patient transfer times, but response times still often lag, and new protocols may be needed to expedite STAT transfers.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme